Sunday, March 03, 2019 1:59:10 AM
The 4 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 5.50, with a high estimate of 6.00 and a low estimate of 5.00. The median estimate represents a +105.99% increase from the last price of 2.67.
The current consensus among 4 polled investment analysts is to buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a buy rating.
Origin
https://money.cnn.com/quote/quote.html?symb=ACHN
Stock Invest says
Today ACHN ranks #1287 as BUY CANDIDATE
StockCharts.com
https://stockcharts.com/h-sc/ui?s=ACHN
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM